Viral Chronicles: The Ever-Evolving Saga of COVID-19

Year : 2024 | Volume :01 | Issue : 01 | Page : –
By

Chandrika Kadam,

  1. Student Trinity College of Pharmacy,Pune Maharashtra India

Abstract

Coronaviruses, belonging to the family of RNA viruses, have recently captured global attention owing to their remarkable ability to infect a diverse array of species, ranging from animals to humans. These viral agents, recognized by their characteristic crown-like morphology when observed through electron microscopy, have a historical association with zoonotic diseases. Previous examples include Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The term “Corona” itself, emblematic of this distinctive morphology, was coined by pioneering virologists June Almeida and David Tyrrell, underscoring the profound impact these viruses have had on scientific understanding and public health.Leading the charge within this viral lineage is the newly identified coronavirus SARS-CoV-2, which serves as the causative agent behind the current COVID-19 pandemic. Its emergence has ushered in a new era of global health crisis, characterized by unprecedented transmission rates and severe respiratory complications. As the virus continues to evolve and adapt, understanding the intricacies of its emergence and mutation becomes paramount.
This paper embarks on a comprehensive exploration of the multifaceted aspects surrounding COVID-19, delving into its zoonotic origins, intricate genomic architecture, mechanisms of replication, and the formidable challenge posed by viral mutations. By unraveling the evolutionary trajectory of SARS-CoV-2, we aim to decipher the underlying mechanisms driving its pathogenicity and transmissibility, thus laying the groundwork for informed public health interventions.Zoonotic spillover events, often facilitated by human-animal interactions, serve as the genesis for novel coronavirus outbreaks. Understanding the dynamics of cross-species transmission is essential for predicting and preempting future pandemics. Moreover, genomic surveillance plays a pivotal role in monitoring viral evolution, detecting emerging variants, and informing vaccine development strategies.
In this endeavor, we aim to contribute to the collective knowledge base surrounding COVID-19, leveraging insights from virology, epidemiology, and molecular biology. By synthesizing the latest scientific evidence and empirical observations, we strive to elucidate the underlying mechanisms driving the emergence and mutation of SARS-CoV-2, thereby empowering public health authorities and policymakers to mount effective responses to the ongoing pandemic.In essence, this paper represents a holistic exploration of the evolutionary dynamics of COVID-19, underscoring the urgent need for interdisciplinary collaboration and evidence-based interventions in the global fight against emerging infectious diseases.

Keywords: Zoonotic disease, Coronavirus, Respiratory syndrome, Replication mechanism, Mutation

[This article belongs to International Journal of Virus Studies(ijvs)]

How to cite this article: Chandrika Kadam. Viral Chronicles: The Ever-Evolving Saga of COVID-19. International Journal of Virus Studies. 2024; 01(01):-.
How to cite this URL: Chandrika Kadam. Viral Chronicles: The Ever-Evolving Saga of COVID-19. International Journal of Virus Studies. 2024; 01(01):-. Available from: https://journals.stmjournals.com/ijvs/article=2024/view=147773



References

  1. Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomedical journal. 2020 Aug 1;43(4):328-33.
  2. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules. 2020 Dec 23;26(1):39.
  3. Pan L, Wang J, Wang X, Ji JS, Ye D, Shen J, Li L, Liu H, Zhang L, Shi X, Wang L. Prevention and control of coronavirus disease 2019 (COVID-19) in public places. Environmental Pollution. 2022 Jan 1;292:118273.
  4. He X, He C, Hong W, Zhang K, Wei X. The challenges of COVID‐19 Delta variant: prevention and vaccine development. MedComm. 2021 Dec;2(4):846-54.
  5. Hadj Hassine I. Covid‐19 vaccines and variants of concern: a review. Reviews in medical virology. 2022 Jul;32(4):e2313.
  6. Plante JA, Mitchell BM, Plante KS, Debbink K, Weaver SC, Menachery VD. The variant gambit: COVID-19’s next move. Cell host & microbe. 2021 Apr 14;29(4):508-15.
  7. Sohrabi C, Alsafi Z, O’neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery. 2020 Apr 1;76:71-6.
  8. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and molecular biology reviews. 2005 Dec;69(4):635-64.
  9. Rajnik M, Cascella M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Uniformed Services University Of The Health Sciences. 2021 Mar 1.
  10. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfusion medicine reviews. 2020 Apr 1;34(2):75-80.
  11. Sohrabi C, Alsafi Z, O’neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery. 2020 Apr 1;76:71-6.
  12. Zhou D, Zhang P, Bao C, Zhang Y, Zhu N. Emerging understanding of etiology and epidemiology of the novel coronavirus (COVID-19) infection in Wuhan, China.
  13. Ganesh A. Epidemiology of Covid–19: An epidemic into a pandemic. Journal of Dental Research and Dental Prospects. 2022;1(01).
  14. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules. 2020 Dec 23;26(1):39.
  15. Nkwoemeka NE, Okwelogu IS, Chiedozie AP. A scoping review on epidemiology, etiology, transmission, clinical presentation, treatment and management of Coronavirus Disease (COVID-19). European journal of biology and medical science research. 2020 Apr;8(2):45-54.
  16. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls [internet]. 2023 Aug 18.
  17. Yavari M, Sanei M, Avakian A. Pathophysiology of Covid-19. Int. Jr. Infect Dis & Epidemlgy. 2022;3(2):40-3.
  18. Ornell F, Moura HF, Scherer JN, Pechansky F, Kessler FH, von Diemen L. The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry research. 2020 Jul 1;289:113096.
  19. Jamil S, Mark N, Carlos G, Cruz CS, Gross JE, Pasnick S. Diagnosis and management of COVID-19 disease. American journal of respiratory and critical care medicine. 2020 May 15;201(10):P19-20.
  20. Bhimraj A, Morgan RL, Shumaker AH, Baden L, Chi-Chung Cheng V, Edwards KM, Gandhi RT, Gallagher JC, Muller WJ, O’Horo JC, Shoham S. Lessons learned from coronavirus disease 2019 (COVID-19) therapies: critical perspectives from the infectious diseases society of America (IDSA) COVID-19 treatment guideline panel. Clinical Infectious Diseases. 2022 May 1;74(9):1691-5.
  21. Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M, Hidalgo A. Early remdesivir to prevent progression to severe Covid-19 in outpatients. New England Journal of Medicine. 2022 Jan 27;386(4):305-15.
  22. Shumaker AH, Bhimraj A. Pharmacologic treatment and management of Coronavirus Disease 2019. Infectious Disease Clinics. 2022 Jun 1;36(2):349-64..
  23. Schwartz DA, Avvad-Portari E, Babál P, Baldewijns M, Blomberg M, Bouachba A, Camacho J, Collardeau-Frachon S, Colson A, Dehaene I, Ferreres JC. Placental tissue destruction and insufficiency from COVID-19 causes stillbirth and neonatal death from hypoxic-ischemic injury: a study of 68 cases with SARS-CoV-2 placentitis from 12 countries. Archives of pathology & laboratory medicine. 2022 Jun 1;146(6):660-76.
  24. Balwan WK, Saba N. Tracking the Coronavirus: Variant of Concern (VOC). Shodhsamhita, VIII (12-VI). 2022.
  25. Ong SW, Chiew CJ, Ang LW, Mak TM, Cui L, Toh MP, Lim YD, Lee PH, Lee TH, Chia PY, Maurer-Stroh S. Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B. 1.1. 7 (Alpha), B. 1.315 (Beta), and B. 1.617. 2 (Delta).
  26. Jungnick S, Hobmaier B, Mautner L, Hoyos M, Haase M, Baiker A, Lahne H, Eberle U, Wimmer C, Hepner S, Sprenger A. In vitro rapid antigen test performance with the SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B. 1.351 (Beta), P. 1 (Gamma), and B. 1.617. 2 (Delta). Microorganisms. 2021 Sep 16;9(9):1967.
  27. Wise J. Covid-19: New coronavirus variant is identified in UK.
  28. Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B, Lambson BE, De Oliveira T, Vermeulen M, Van der Berg K, Rossouw T. SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma. Nature medicine. 2021 Apr;27(4):622-5.
  29. Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CA, Russell TW, Tully DC, Washburne AD, Wenseleers T. Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England. Science. 2021 Apr 9;372(6538):eabg3055.
  30. Lythgoe KA, Hall M, Ferretti L, de Cesare M, MacIntyre-Cockett G, Trebes A, Andersson M, Otecko N, Wise EL, Moore N, Lynch J. SARS-CoV-2 within-host diversity and transmission. Science. 2021 Apr 16;372(6539):eabg0821.
  31. O’Toole Á, Hill V, Pybus OG, Watts A, Bogoch II, Khan K, Messina JP, COVID T, Network BU, Tegally H, Lessells RR. Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch. Wellcome Open Research. 2021;6.
  32. Corum J, Zimmer C. Inside the B. 1.1. 7 Coronavirus Variant. The New York Times. 2021 Jan 18;18.
  33. da Silva JF, Esteves RJ, Siza C, Soares EP, Ramos TC, Campelo EC, da Costa CF, de Alencar LC, Cavalcante RP, Florêncio CR, Mattos TP. Cluster of SARS-coV-2 gamma variant infections, parintins, Brazil, march 2021. Emerging infectious diseases. 2022 Jan;28(1):262.
  34. Naveca FG, Nascimento V, Souza V, Corado AD, Nascimento F, Silva G, Mejía MC, Brandão MJ, Costa Á, Duarte D, Pessoa K. Spread of Gamma (P. 1) sub-lineages carrying Spike mutations close to the furin cleavage site and deletions in the N-terminal domain drives ongoing transmission of SARS-CoV-2 in Amazonas, Brazil. Microbiology Spectrum. 2022 Feb 23;10(1):e02366-21.
  35. Papanikolaou V, Chrysovergis A, Ragos V, Tsiambas E, Katsinis S, Manoli A, Papouliakos S, Roukas D, Mastronikolis S, Peschos D, Batistatou A. From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants. Gene. 2022 Mar 10;814:146134.
  36. Del Rio C, Malani PN, Omer SB. Confronting the delta variant of SARS-CoV-2, summer 2021. Jama. 2021 Sep 21;326(11):1001-2.
  37. Hageman JR, Alcocer Alkureishi L. Omicron: A Variant of Concern?. Pediatric Annals. 2022 Jan 1;51(1):e1-.
  38. Tian D, Sun Y, Xu H, Ye Q. The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant. Journal of medical virology. 2022 Jun;94(6):2376-83.

Regular Issue Subscription Review Article
Volume 01
Issue 01
Received April 4, 2024
Accepted May 26, 2024
Published May 27, 2024